PhotoIf confirmed, Mr. Price, 62, will soon have far more power to influence the nation’s vast health care system than he ever did as a lawmaker. So, too, is Mr. Price’s history of trading in biomedical, pharmaceutical and health insurance stocks while serving on the health subcommittee of the House Ways and Means Committee. The regulation sought to rein in spending on joint replacements for Medicare patients; Mr. Price’s legislation would have delayed its implementation. Mr. Price has also supported proposals to overhaul Medicare — potentially putting him at odds with his new boss, Mr. Trump, who has pledged not to “touch” the program. Speaking to a student group at the University of Michigan in 2015, Mr. Price expressed concern that Mr. Trump would not listen to others, including Congress, if elected.

Source: New York Times January 17, 2017 00:53 UTC